Intraoperative hypotension and short-term outcomes after primary total hip arthroplasty : a retrospective cohort study.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 42259510.
- Also identified by DOI 10.1302/2633-1462.76.BJO-2026-0009.R1.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Intraoperative hypotension (IOH) has been associated with adverse outcomes in non-cardiac surgery, but its effect during total hip arthroplasty (THA) remains unclear. This study aimed to investigate whether absolute (AIOH) or relative (RIOH) IOH is a risk factor for adverse short-term outcomes following primary THA. A retrospective review of 394 THAs (394 patients) performed at a single academic institution between September 2020 and April 2025 was conducted. AIOH was defined as any intraoperative mean arterial pressure (MAP) < 65 mmHg, and RIOH as a ≥ 20% decrease from preoperative baseline MAP. Primary outcomes included all-cause 30- and 90-day readmissions and postoperative length of stay (LOS). Multivariable logistic regression was used to identify predictors of readmission and LOS > one day. Overall, 112 patients (28.4%) experienced AIOH during their THA. Neither the presence nor duration of AIOH was associated with readmission or LOS. RIOH occurred in 74 patients (22.5%), and was not associated with readmission or LOS, but was associated with higher rates of reoperation within 90 days (12.2% vs 2.4%, p = 0.001). Estimated blood loss independently predicted prolonged LOS across all models (odds ratio 1.75 per 50 ml, 95% CI 1.33 to 2.31, p < 0.001). AIOH was not associated with an increased risk of adverse short-term outcomes following primary THA when defined by a fixed MAP threshold. RIOH and intraoperative blood loss demonstrated stronger associations with postoperative complications, but these findings require further evaluation. This study supports a more individualized approach to haemodynamic monitoring in primary THA.